Concepedia

Robert H.I. Andtbacka

RH

Statistics

Publications

77

Citations

12K

H-Index

38

Active since

2001

Affiliations

Huntsman Cancer Institute(Current)

University of Utah

The University of Texas MD Anderson Cancer Center

Moffitt Cancer Center

Geriatric Research Education and Clinical Center

Robert H.I. Andtbacka is an author at Huntsman Cancer Institute specializing in oncology, medicine, and immunotherapy.

Publications per year

2001–2024

77

Publications

77

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio et al. · Journal of Clinical Oncology · 2015 · 2.6K citations · Full text

Medicine, Immunology, Oncology +17

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy

Antoni Ribas, Reinhard Dummer, Igor Puzanov et al. · Cell · 2017 · 1.5K citations · Full text

Medicine, Immunology, Oncology +12

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

Mark B. Faries, John F. Thompson, Alistair J. Cochran et al. · New England Journal of Medicine · 2017 · 1.4K citations · Full text

Medicine, Oncology, Surgery +17

Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma

Jason Chesney, Igor Puzanov, Frances A. Collichio et al. · Journal of Clinical Oncology · 2017 · 617 citations

Medicine, Oncology, Pharmacotherapy +17

Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma

Igor Puzanov, Mohammed Milhem, David R. Minor et al. · Journal of Clinical Oncology · 2016 · 550 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–5 of 77